OTC drug private label makers seek more time to comply with labeling regs.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABEL REG: PRIVATE LABELERS SEEK MORE TIME TO COMPLY with FDA's Feb. 27 proposed revisions to over-the-counter drug labels at an agency "feedback" meeting in Rockville, Md. Sept. 30. The Private Label Manufacturers Association, which represents over 2,500 retailers, manufacturers and distributors of store brand products, likely will ask FDA for an additional year or two to come into compliance with final requirements of the OTC drug product labeling reg. The final rule revising OTC drug labeling is expected in a year and will take effect two years after issuance.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning